Recurrent head and neck squamous cell carcinoma Clinical Trials

Delta Trials catalogs 46 clinical trials for Recurrent head and neck squamous cell carcinoma in its publicly accessible dataset. Within this set, 19 currently recruiting participants and 7 trials have reached completion. This research occurs across 474 participating sites around the world. An additional 20 trials are in other active phases such as not yet recruiting or pending status. Since 2020, 6 trials were withdrawn or terminated prior to completion. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations and statuses evolve over time.